Integral Health Asset Management, LLC Edwards Lifesciences Corp Transaction History

Integral Health Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $12.6 Million - $14.1 Million	150,000 New	150,000 $13.9 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $4.59 Million - $5.78 Million	-45,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $1.06 Million - $1.31 Million	10,000 Added 28.57%	45,000 $5.83 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $3.09 Million - $3.68 Million	-30,000 Reduced 46.15%	35,000 $3.96 Million
Q2 2021 Aug 30, 2021	SELL	$83.84 - $104.76 $5.45 Million - $6.81 Million	-65,000 Reduced 50.0%	65,000 $6.73 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $10.9 Million - $13.6 Million	130,000 New	130,000 $13.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $2.15 Million - $2.74 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $2.02 Million - $2.62 Million	30,000 New	30,000 $2.4 Million

1,364

470M

9.76M

3.89M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.